Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Merck and Sirna | Main | GSK: More Cuts Coming »

January 29, 2010

Johnson May Have Been On to Something

Email This Entry

Posted by Derek

The crew at Angewandte Chemie has produced another head-shaking pun in one of their latest abstracts. Read only if (1) you know your 1980s music, and (2) you have a high tolerance for wordplay. When I was in Germany, this sort of joke was known as an "eiskalter" and was greeted with shivers.

Comments (10) + TrackBacks (0) | Category: The Scientific Literature


COMMENTS

1. Bob in FWB, FL on January 29, 2010 12:30 PM writes...

Too many puns like that will have you walkin' like an Egyptian.

Permalink to Comment

2. Old Timer on January 29, 2010 12:34 PM writes...

When I was in graduate school, one of my labmates had a Mannich reaction right in the middle of his total synthesis. Sadly, whenever he'd be bring up more material, this very pun was thrown around often.

Permalink to Comment

3. PJ Hansen on January 29, 2010 12:54 PM writes...

Great! Now it's stuck in my head. Never thought your site would be the source of ear-worms.

Permalink to Comment

4. J-bone on January 29, 2010 1:21 PM writes...

Too many puns like that will have you walkin' like an Egyptian.

Or wishin' it was Sunday.

Permalink to Comment

5. RB Woodweird on January 29, 2010 1:50 PM writes...

My I-don't-have-to-run-a-reaction day.

Permalink to Comment

6. PharmaHeretic on January 29, 2010 2:01 PM writes...

Food for thought..
_______________
Pfizer trims drug pipeline after Wyeth merger
Wed, Jan 27 2010

* Pfizer cuts 100 drug-development projects
* Pulls Lyrica application as add-on anxiety drug
* Aims to sell, outlicense many discontinued assets

By Bill Berkrot and Ransdell Pierson

NEW YORK, Jan 27 (Reuters) - Pfizer Inc said on Wednesday it has cut more than 15 percent of its combined drug development programs following the recent merger with Wyeth and will no longer seek U.S. approval to sell pain drug Lyrica as an add-on treatment for anxiety.

Permalink to Comment

7. Sili on January 29, 2010 2:05 PM writes...

Cute. Even I got it.

If I ever get back in the lab, I think I want to some Mannich reactions with yellow products.

Permalink to Comment

8. martin on January 29, 2010 8:55 PM writes...

Do you like Pinacol-adas?

Permalink to Comment

9. Funny on January 29, 2010 9:34 PM writes...

Check this out!!!!!


Www.rezaghadiri.net

Permalink to Comment

10. Dr Van Nostrand on February 1, 2010 8:36 AM writes...

Tell me why
I don’t like Mondays
Tell me why
I don’t like Mondays
Tell me why
I don’t like Mondays
I wanna shoo-oo-oo-oo-oo-oot the whole day down

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Gitcher SF5 Groups Right Here
Changing A Broken Science System
One and Done
The Latest Protein-Protein Compounds
Professor Fukuyama's Solvent Peaks
Novartis Gets Out of RNAi
Total Synthesis in Flow
Sweet Reason Lands On Its Face